<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drugDebug/PMC7102587/results/search/country/results.xml">
  <result pre="search and a narrative review with a special reference to" exact="India" post="and other developing countries SinghAwadhesh Kumardraksingh_2001@yahoo.coma∗SinghAkritibShaikhAltamashcSinghRituaMisraAnoopdef[a], [b], [c], [d],"/>
  <result pre="been approved in the treatment of type 2 diabetes in" exact="India" post="since 2014 as a third- or fourth-line drug, it"/>
  <result pre="disease (e.g. rheumatic diseases). Approved for treatment of T2DM in" exact="India" post="Remdesivir Adenosine nucleotide analogues Inhibits viral application Effective against"/>
  <result pre="available in a letter form, interestingly, this early result led" exact="China" post="to include chloroquine in the prevention and treatment of"/>
  <result pre="COVID-19 pneumonia. Moreover, The National Health Commission of the People’s" exact="Republic of" post="China recommended inclusion of chloroquine in the next version"/>
  <result pre="Moreover, The National Health Commission of the People’s Republic of" exact="China" post="recommended inclusion of chloroquine in the next version of"/>
  <result pre="preventing community transmission of COVID-19. Since the data from Wuhan," exact="China" post="showed that some patients were carrier as long as"/>
  <result pre="Control Trial (THDMS-COVID19) Treatment Antiviral drugs plus Chloroquine PBO 80" exact="Thailand" post="NCT04303299 Chloroquine Prevention of Coronavirus Disease (COVID-19) in the"/>
  <result pre="prophylaxis in two separate groups Darunavir/Cobicistat plus Chloroquine PBO 3040" exact="Germany" post="NCT04304053 The Clinical Study of Carrimycin on Treatment Patients"/>
  <result pre="Patients With COVID-19 Treatment Carrimycin Lopinavir/ritonavir Arbidol Chloroquine PBO 520" exact="China" post="NCT04286503 Comparison of Lopinavir/Ritonavir or Hydroxychloroquine in Patients with"/>
  <result pre="of Pneumonia Caused by 2019-nCoV (HC-nCoV) Treatment HCQ PBO 30" exact="China" post="NCT04261517 Post-exposure Prophylaxis for SARS-Coronavirus-2 Post exposure prophylaxis HCQ"/>
  <result pre="Post-exposure Prophylaxis for SARS-Coronavirus-2 Post exposure prophylaxis HCQ PBO 1500" exact="United States" post="NCT04308668 HCQ-hydroxychloroquine, PBO- placebo, N - number. Future directions:"/>
  <result pre="further studies. 4.Use of HCQ in patients with diabetes in" exact="India" post="where it is already approved for treatment: It would"/>
 </snippets>
</snippetsTree>
